Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.48
-0.83 (-6.24%)
May 7, 2026, 4:08 PM HKT
Market Cap6.08B
Revenue (ttm)146.34M
Net Income-379.87M
EPS-0.88
Shares Out456.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,180,200
Average Volume945,350
Open13.48
Previous Close13.31
Day's Range12.33 - 13.93
52-Week Range12.33 - 74.00
Betan/a
RSI23.43
Earnings DateMay 13, 2026

About HKG:2591

Guangzhou Innogen Pharmaceutical Group Co., Ltd engages in the development of drugs. The company’s products are used for the treatment of metabolic diseases, including diabetes, obesity, and MASH; and other major central nervous system diseases. The company was incorporated in 2014 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2591
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements